Leaving the study early · persistent aggressive behaviour or agitation in people with schizophrenia
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
H2 antagonists showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
Monoamine modulators showed no clear difference in leaving the study early: for any reason compared with placebo (low certainty).
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
Topiramate showed no clear difference in leaving the study early: for any reason compared with placebo or no treatment (low certainty).
1 finding from 1 review
Leaving the study early · people with schizophrenia with antipsychotic‐induced weight gain
It is very uncertain whether metformin changes leaving the study early: for any reason compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
It is very uncertain whether humour‐based interventions changes leaving the study early for any reason compared with standard care (very low certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
1 finding from 1 review
Leaving the study early · Adolescents with psychosis
It is very uncertain whether GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU changes leaving the study early: For any reason compared with TAU (all short‐term) (very low certainty).
1 finding from 1 review
Leaving the study early · Adolescents with psychosis
STRUCTURAL GROUP THERAPY (SGT) + TAU showed no clear difference in leaving the study early: For any reason compared with HANDICRAFT GROUP (HC) + TAU (all short‐term) (low certainty).
1 finding from 1 review
Leaving the study early · Adolescents with psychosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Leaving the study early · Adolescents with psychosis
It is very uncertain whether COMPUTER‐ASSISTED COGNITIVE REMEDIATION PROGRAMME (CACR) changes leaving the study early: For any reason compared with COMPUTER GAMES (CG, all short‐term) (very low certainty).
1 finding from 1 review
Leaving the study early · Adolescents with psychosis
PSYCHOEDUCATIONAL (PE) + MULTIFAMILY TREATMENT (MFT) showed no clear difference in leaving the study early: For any reason compared with NONSTRUCTURED GROUP THERAPY (NSGT, all long‐term) (low certainty).
1 finding from 1 review
Leaving the study early · Adolescents with psychosis
It is very uncertain whether COGNITIVE REMEDIATION THERAPY (CRG) + TREATMENT‐AS‐USUAL (TAU) changes leaving the study early: For any reason compared with TAU (all short‐term) (very low certainty).
1 finding from 1 review
Leaving the study early · schizophrenia
Mirtazapine adjunct showed no clear difference in leaving the study early for any reason compared with placebo adjunct (moderate certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
It is very uncertain whether chlorpromazine changes leaving the study early: for any reason compared with clotiapine (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether EMDR changes leaving the study early for any reason compared with non‐TFCBT (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether group TFCBT changes leaving the study early for any reason compared with waitlist/Usual Care (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with waitlist/Usual Care (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review